13F-HR filed by NEA Management Company, LLC
NEA Management Company, LLC filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-13, with 44 holding rows worth $2,317,411,000.
- Accession
- 0001012975-18-001207
- Filer
- CIK 1512848
- Filed
- 2018-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2018
A holdings report, 44 entries on the cover page, a total value of $2,317,411,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,317,411,000 with VALUE read as thousands by filing date, 13F file number 028-14302. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TESARO INC | 881569107 | COM | 10,420,555 | $406,506,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 15,832,611 | $214,690,000 | thousands by filing date | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 30,888,266 | $147,337,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 4,912,306 | $143,292,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 9,089,041 | $130,882,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 2,268,188 | $102,046,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 5,493,636 | $99,380,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 2,090,678 | $92,722,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 4,586,563 | $82,696,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 8,144,267 | $81,443,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 6,460,851 | $68,485,000 | thousands by filing date | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 2,486,062 | $68,193,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 15,335,047 | $66,707,000 | thousands by filing date | |
| AVEO PHARMACEUTICALS INC | 053588109 | COM | 18,698,038 | $61,891,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 4,229,410 | $60,100,000 | thousands by filing date | |
| BLOOM ENERGY CORP | 093712107 | COM | 1,333,333 | $45,440,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 3,506,649 | $38,222,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 3,315,149 | $36,268,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 4,808,483 | $31,928,000 | thousands by filing date | |
| CHAMPIONS ONCOLOGY INC | 15870P307 | COM NEW | 1,562,500 | $27,297,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 10,989,010 | $26,044,000 | thousands by filing date | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 2,382,286 | $25,419,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 5,720,572 | $24,656,000 | thousands by filing date | |
| CLEMENTIA PHARMACEUTICALS IN | 185575107 | COM | 2,141,697 | $23,880,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 5,138,888 | $22,354,000 | thousands by filing date | |
| ACHAOGEN INC | 004449104 | COM | 5,215,128 | $20,808,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 4,141,308 | $20,085,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427104 | COM | 25,000,000 | $19,500,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 1,219,674 | $15,258,000 | thousands by filing date | |
| NIGHTSTAR THERAPEUTICS PLC | 65413A101 | ADR | 714,285 | $14,593,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 2,520,316 | $14,265,000 | thousands by filing date | |
| DASAN ZHONE SOLUTIONS INC | 23305L206 | COM NEW | 956,255 | $13,569,000 | thousands by filing date | |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 5,556,778 | $13,392,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 3,243,150 | $10,411,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 3,750,000 | $8,100,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 3,811,691 | $8,081,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 1,250,000 | $7,250,000 | thousands by filing date | |
| TRACON PHARMACEUTICALS INC | 89237H100 | COM | 3,467,181 | $7,108,000 | thousands by filing date | |
| PHAXIAM THERAPEUTICS S A | 29604W108 | SPONSORED ADR | 625,000 | $5,356,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 2,490,204 | $4,756,000 | thousands by filing date | |
| Arsanis Inc | 042873109 | COM | 2,000,000 | $3,240,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 1,298,274 | $2,597,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 452,167 | $1,158,000 | thousands by filing date | |
| AYTU BIOSCIENCE INC | 054754700 | COM PAR | 2,246 | $6,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-18-001207 | this filing | 2018-11-13 | acceptance time not in the bulk data set |